WebmedCentral.com :: Article Review View

Bisphosphonate-induced Jaw Osteonecrosis

Posted by Dr. William J Maloney on 07 Feb 2014 08:03:42 PM GMT Reviewed by Interested Peers

What are the main claims of the paper and how important are they?
The author's aim is to provide clinical recommendations on prevention and management of individuals who have beem administered bisphosphonates intravenously.
Are these claims novel? If not, please specify papers that weaken the claims to the originality of this one.
Yes
Are the claims properly placed in the context of the previous literature?

Yes
Do the results support the claims? If not, what other evidence is required?

Yes
If a protocol is provided, for example for a randomized controlled trial, are there any important deviations from it? If so, have the authors explained adequately why the deviations occurred?

No
Is the methodology valid? Does the paper offer enough details of its methodology that its experiments or its analyses could be reproduced?

Yes
Would any other experiments or additional information improve the paper? How much better would the paper be if this extra work was done, and how difficult would such work be to do, or to provide?

No
Is this paper outstanding in its discipline? (For example, would you like to see this work presented in a seminar at your hospital or university? Do you feel these results need to be incorporated in your next general lecture on the subject?) If yes, what makes it outstanding? If not, why not?
Yes- it would be a very nice lecture for all dentists.
Other Comments:
Bisphosphonate-induced jaw osteonecrosis (BJON) is highly associated with two intravenous bisphosphonate formulations. Dentists need to be aware of the possibility of BJON which can occur spontaneously or after any dentoalveolar procedure in the population at risk. Early referral to the proper specialist is paramount once BJON is suspected.
Competing interests:
None
Invited by the author to review this article? :
No
Have you previously published on this or a similar topic?:
No
References:

None
Experience and credentials in the specific area of science:

Clinical associate professor
How to cite: Maloney W J.Bisphosphonate-induced Jaw Osteonecrosis[Review of the article 'Bisphosphonate-induced Jaw Osteonecrosis (BJON) & its Management Strategy ' by Dayma V].WebmedCentral 2012;5(2):WMCRW002957

Rating
Rating	1	2	3	4	5	6	7	8	9

Report abuse

Comment on Bisphosphonates manuscript

Posted by Dr. Constantino Ledesma-Montes on 26 Apr 2012 04:00:25 PM GMT

1	Is the subject of the article within the scope of the subject category?	Yes
2	Are the interpretations / conclusions sound and justified by the data?	Yes
3	Is this a new and original contribution?	No
4	Does this paper exemplify an awareness of other research on the topic?	Yes
5	Are structure and length satisfactory?	Yes
6	Can you suggest brief additions or amendments or an introductory statement that will increase the value of this paper for an international audience?	No
7	Can you suggest any reductions in the paper, or deletions of parts?	No
8	Is the quality of the diction satisfactory?	Yes
9	Are the illustrations and tables necessary and acceptable?	Yes
10	Are the references adequate and are they all necessary?	Yes
11	Are the keywords and abstract or summary informative?	Yes

Other Comments:
It is a well done and interesting manuscript.
Competing interests:
No
Invited by the author to review this article? :
No
Have you previously published on this or a similar topic?:
No
References:
None
Experience and credentials in the specific area of science:

I attend bisphosphonate patients in my Oral and Maxillofacial Diagnosis Clinic.
How to cite: Ledesma-Montes C .Comment on Bisphosphonates manuscript[Review of the article 'Bisphosphonate-induced Jaw Osteonecrosis (BJON) & its Management Strategy ' by Dayma V].WebmedCentral 2012;3(4):WMCRW001736

Rating
Rating	1	2	3	4	5	6	7	8	9

Report abuse

Reviews